The Delhi High Court has issued a directive to the central government, urging the formulation of a policy governing the online sale of medicines within the next eight weeks. The court, taking note of the protracted nature of the case spanning five years, has underscored that this represents the final opportunity for the central government to establish such a policy. Non-compliance may lead to the personal appearance of the relevant joint secretary in court at the upcoming hearing.
In response to petitions seeking a ban on illicit online medicine sales, the court has issued an order challenging proposed amendments to the Drugs and Cosmetics Rules and the Pharmacy Act by the Ministry of Health and Family Welfare. It’s noteworthy that in December 2018, the High Court had previously mandated a cessation of online medicine sales, citing violations of the Drugs and Cosmetics Act, 1940, and the Pharmacy Act, 1948.
Despite previous court directives, there persists a call for decisive action against the government’s inaction towards e-pharmacies. A fresh application has been lodged with the Delhi High Court, urging measures against e-pharmacies for their continued online medicine sales. E-pharmacies assert that they do not require a license for online medicine delivery, drawing a parallel to food delivery apps like Swiggy, emphasizing that they solely provide delivery services for medicines.
The Taliban’s regime has since imposed over 100 laws restricting women's rights, stripping them of…
These gifts to world leaders reflect the diverse traditions, arts, and crafts of India, emphasizing…
Dr Singh stressed the importance of reaching a GDP of $15 trillion by 2047 to…
Criminal lawyer Vijay Aggarwal weighed in on the charges against Adani. He believes the indictment…
After a major sell-off earlier in the week, Adani Group stocks, led by Ambuja Cements…
A sharp rally in financial stocks and encouraging US labor market data fueled the uptrend.…